首页  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact Us
 
当期目录  |  过刊浏览  |  阅读排行  |  下载排行  |  引用排行

Medicine Research ›› 2024, Vol. 8 ›› Issue (1): 230010-230010.DOI: 10.21127/yaoyimr20230010

• • 上一篇    下一篇

  

  • 收稿日期:2023-10-06 接受日期:2023-11-28 出版日期:2024-03-20 发布日期:2024-04-25

A Perspective of 6,12-Guaianolides and Their Analogues: Synthesis, Bioactivity and Structure-Activity Relationships

Ruihua Guoa,*, Guo Y. Yinb, Ruilong Shengc,*   

  1. aCollege of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China;
    b10132 Baylee Ln, San Diego, CA 92127, United States;
    cCQM - Centro de Química da Madeira, Universidade da Madeira, Campus da Penteada, 9000-390 Funchal, Portugal
  • Received:2023-10-06 Accepted:2023-11-28 Online:2024-03-20 Published:2024-04-25
  • Contact: Email: rhguo@shou.edu.cn (R. G.); ruilong.sheng@staff.uma.pt (R. S.)

Abstract: Recently, the study on 6,12-guaianolides, a family of natural guaiane-type sesquiterpenoids, has attracted increased attention in the field of chemical synthesis, pharmaceutics, and medicinal chemistry. Many 6,12-guaianolide compounds and their analogues showed remarkable molecular diversity, structural modifiability, and versatile biological and pharmacological properties, such as anticancer, antivirus, anti-inflammatory, endogenous NO production inhibition, and so on. In this paper, we summarized recent advances on the synthesis methods of 6,12-guaianolides and their analogues, briefly described their bioactivities, and elucidated the quantitative structure-activity relationship of some 6,12-guaianolides and their analogues. Furthermore, the perspectives of 6,12-guaianolides and their analogues were discussed.

Key words: guaiane-type sesquiterpenoids, cytotoxicity, NO inhibition, quantitative structure-activity relationship

版权所有 © 《Medicine Research》编辑部
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn
总访问量: